ARTICLE | Clinical News
Avectin gene transfer technology: Trial to begin after FDA filing
September 19, 1994 7:00 AM UTC
Applied Immune Sciences Inc. (AISX), Santa Clara, Calif. Product: Avectin gene transfer technology, which uses viral elements and liposomes, to transfer the gene for interleukin-2 into tumor cells Ind...